DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment

 

 

Cardiology Homepage

MaxQ-AI seeks $8 million public IPO listing on Nasdaq Will help FDA regulatory processes for Accipio software products

Boston Scientific to buy VENITI for $160 million Price may rise pending FDA approval of Vici Venous Stent

NIH grants $1.5 million to Magnetic Insight for development of new imaging modality Uses non-radioactive, iron oxide nanoparticle tracer

MR-conditional labeling now available for Abbotts Infinity DBS system First FDA-cleared MR-conditional directional DBS system

Boston Scientific to acquire TAVR protection system with purchase of Claret Medical Will acquire ownership of the Sentinel System

Viz.ai to extend LVO AI-based platform beyond stroke Using $21 million from Series A funding to do so

Fewer ICDs are failing to comply with CMS NCD standards, says study Follows DOJ investigation into overuse of non-NCD-compliant ICDs

DaVita hit with $383.5 million jury verdict in dialysis death suit Three patients suffered cardiac arrest after getting GranuFlo therapy

New research finds leadless pacemakers cause fewer complications than conventional option Will they become the new standard?

Ivor Benjamin American Heart Association seats new president and officers as chairman enters 2nd of two-year term

Wearable defibrillators may be an effective
and safe alternative for children with
arrhythmias who are not suitable
for implants

Cardioverter defibrillator vest may be viable alternative to pediatric implants

por John R. Fischer , Staff Reporter
Children unable to undergo cardiac implants for heart arrhythmias may be able to wear a vest instead.

That vest in question is a wearable cardioverter defibrillator which may be a safe and effective alternative for children with ventricular heart rhythm disorders that pose the risk of sudden cardiac arrests or deaths, according to researchers in the largest U.S. pediatric study to date.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



“Our results, which stem from the largest study to date among children in the United States using wearable cardioverter defibrillators, suggest that these external devices can help save the lives of children who are, at the time, not good candidates for surgically implanted defibrillators because of their medical condition,” said the study’s principal investigator David Spar, assistant professor of pediatrics at the University of Cincinnati and a pediatric electrophysiologist at Cincinnati Children’s Hospital, in a statement.

Surgically implanted cardioverter defibrillators are the main choice of treatment for children with arrhythmias, but may not be a good option in children who require only a temporary “bridge” to help their heart. Such procedures also involve invasive surgery or prolonged hospitalization.

Though approved for use in pediatric patients in 2015 by the FDA, research on the effective and safe use of wearable cardioverter defibrillators is limited, creating a lack of understanding and hesitancy in providing it to children with dangerous arrhythmias.

Researchers tested these aspects on eight out of 455 patients whose average age was 15. All eight received at least one shock treatment to interrupt dangerous heart rhythms.

Six benefited from the therapy with the device detecting and stopping their condition. The device misread a signal in two of the patients; though misfiring in all cases, dangerous heart rhythm was successfully interrupted, enabling normal heart rhythm to return and the patient to survive.

The findings are the first to describe appropriate therapy with a wearable cardioverter defibrillator for children, and indicate that such devices could offer protection for arrhythmias without prolonged hospitalization.

The results are based on a review of clinical outcomes among all U.S. pediatric patients who wore cardioverter defibrillators between 2009 and 2016.

Coauthors on the study were Nicole Bianco, Ph.D.; Timothy Knilans, M.D.; Richard, Czosek, M.D.;and Jeffrey Anderson, M.D.

No outside sources were used for funding.

The findings were published in Circulation: Arrhythmia and Electrophysiology, an American Heart Association journal.

Cardiology Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2018 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS